Medical devices, healthcare technology and the business of care
510(k) clearance · K262025

Innovasis AxTiHA Stand-Alone ALIF System;Innovasis TxTiHA IBF System;Innovasis HAtetracell-C Titanium Cervical IBF System

INNO Holdings Inc. DBA Innovasis · Decision date Sep 11, 2026

FDA DECISIONK262025

What did the FDA decide?

FDA records K262025 as a 510(k) premarket notification, with a decision dated Sep 11, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 11, 2026

FDA source record

Regulatory record facts

Identifier
K262025
Regulatory pathway
510(k) premarket notification
Product code
OVD
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intervertebral Fusion Device With Integrated Fixation, Lumbar.

Product code
OVD
FDA device class
2

FDA decision timeline

  1. K262025 received

    Application receipt date recorded by FDA.

  2. K262025 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OVD

Product / regulatory recordCompanyPathwayDecision dateSource
Elevation Spine510(k) clearanceAug 3, 2026FDA
Foundation Surgical Group510(k) clearanceJul 31, 2026FDA
KYOCERA MEDICAL TECHNOLOGIES, INC.510(k) clearanceJul 15, 2026FDA
Tyber Medical, LLC510(k) clearanceJun 10, 2026FDA
Medacta International S.A.510(k) clearanceMay 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

INNO Holdings Inc. DBA Innovasis

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Salt Lake City, UT

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records